Advertisement

Leukotrienes pp 95-102 | Cite as

Transcription factors HSF and NF-КB as targets for cytoprotective eicosanoids: a new strategy for therapeutic intervention

  • M. G. Santoro
Chapter

Abstract

The observation that an increase in temperature of a few degrees above the physiological level induces the synthesis of a small number of proteins in Drosophila salivary glands led to the discovery of a universal protective mechanism which prokaryotic and eukaryotic cells utilize to preserve cellular function and homeostasis1. This complex physiological defence mechanism, known as the heat shock response, involves the rapid induction of a specific set of genes encoding cytoprotective proteins (heat shock protein, HSP). In mammalian cells HSP synthesis is induced in a wide variety of toxic conditions, including extreme temperatures, oxidative stress, exposure to heavy metals or cytotoxic drugs, glucose deprivation and virus infection1. Whereas HSP induction was at first interpreted as a signal for detection of physiological stress, it is now well-documented that HSPs are utilized by the cells in the repair process following different types of injury, to prevent damage resulting from the accumulation and aggregation of non-native proteins2.

Keywords

Heat Shock Protein Heat Shock Response Heat Shock Transcription Factor Sodium Arsenite Human Heat Shock Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Linguist S, Craig EA. The heat shock proteins. Annu Rev Genet. 1988; 22: 631–77.CrossRefGoogle Scholar
  2. 2.
    Feige U, Morimoto RI, Yahara I, Polla BS. Stress-Inducible Cellular Responses. Basel-Boston-Berlin: Birkhäuser-Verlag, 1996.Google Scholar
  3. 3.
    Morimoto RI, Sarge KD, Abravaya K. Transcriptional regulation of heat shock genes. J Biol Chem. 1992; 267: 21987–90.PubMedGoogle Scholar
  4. 4.
    Sistonen L, Sarge KD, Phillips B, Abravaya K, Morimoto RI. Activation of heat shock factor 2 during hemin-induced differentiation of human erythroleukemia cells. Mol Cell Biol. 1992; 12: 4104–11.PubMedGoogle Scholar
  5. 5.
    Santoro MG, Garaci E, Amici C. Prostaglandins with antiproliferative activity induce the synthesis of a heat shock protein in human cells. Proc Natl Acad Sci USA. 1989; 86: 8407–11.PubMedCrossRefGoogle Scholar
  6. 6.
    Williams RS, Thomas JA, Fina M, German Z, Benjamin IJ. Human heat shock protein 70 (hsp70) protects murine cells from injury during metabolic stress. J Clin Invest. 1993; 92: 503–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Polla BS, Cossarizza A. Stress proteins in inflammation. In: Feige U, Morimoto RI, Yahara I, Polla BS, editors. Stress-Inducible Cellular Responses. Basel-Boston-Berlin: BirkhäuserVerlag, 1996: 375–91.CrossRefGoogle Scholar
  8. 8.
    Amici C, Giorgi C, Rossi A, Santoro MG. Selective inhibition of virus protein synthesis by prostaglandin A: A translational block associated with HSP70 synthesis. J Virol. 1994; 68: 6890–9.PubMedGoogle Scholar
  9. 9.
    Mestril R, Chi SH, Sayen MR, O’Reilly K, Dillmann WH. Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against stimulated ischemiainduced injury. J Clin Invest. 1994; 93: 759–67.PubMedCrossRefGoogle Scholar
  10. 10.
    Marber MS, Walker JM, Latchman DS, Yellon DM. Myocardial protection after whole body heat stress in the rabbit is dependent on metabolic substrate and is related to the amount of the inducible 70-KD heat stress protein. J Clin Invest. 1994; 93: 1087–94.PubMedCrossRefGoogle Scholar
  11. 11.
    Plumier J, Ross BM, Currie RW, et al. Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest. 1995; 95: 1854–60.CrossRefGoogle Scholar
  12. 12.
    Morris SD, Cumming DV, Latchman DS, Yellon DM. Specific induction of the 70-kD heat stress protein by the tyrosine kinase inhibitor herbimycin-A protects rat neonatal cardiomyocytes. J Clin Invest. 1996; 97: 706–12.PubMedCrossRefGoogle Scholar
  13. 13.
    Iaattela M, Wissing D, Bauer PA, Li GC. Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J. 1992; 11: 3507–12.Google Scholar
  14. 14.
    Feinstein DL, Galea E, Aquino DA, Li GC, Xu H, Reis DJ. Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NF-KB activation. J Biol Chem. 1996; 271: 17724–32.PubMedCrossRefGoogle Scholar
  15. 15.
    Villar J, Edelson JD, Post M, Brendan J, Mullen M, Slutsky AS. Induction of heat stress proteins is associated with decreased mortality in an animal model of acute lung injury. Am Rev Resp Dis. 1993; 147 177–81PubMedCrossRefGoogle Scholar
  16. 16.
    Santoro MG. Viral infection. In: Feige U, Morimoto RI, Yahara I, Polla BS, editors. Stress-Inducible Cellular Responses. Basel-Boston-Berlin: Birkhäuser-Verlag, 1996 337–57.CrossRefGoogle Scholar
  17. 17.
    Santoro MG, Garaci E, Amici C. Induction of HSP70 by prostaglandins. In: Schlesinger MJ, Santoro MG, Garaci E, editors. Stress Proteins: Induction and Function. Berlin: Springer-Verlag, 1990: 27–44.CrossRefGoogle Scholar
  18. 18.
    Santoro MG. Heat shock proteins and virus replication: Hsp7Os as mediators of the antiviral effects of prostaglandins. Experientia. 1994; 50: 1039–47.PubMedCrossRefGoogle Scholar
  19. 19.
    Amici C, Sistonen L, Santoro MG, Morlmoto RI. Antiproliferative prostaglandins activate heat shock transcription factor. Proc Natl Acad Sci USA. 1992: 89: 6227–31.PubMedCrossRefGoogle Scholar
  20. 20.
    Kliewer SA, Lenhard JM, Wilson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 1995; 83: 813–19.PubMedCrossRefGoogle Scholar
  21. 2l.
    Rossi A, Elia G, Santoro MG. Inhibition of nuclear factor κB by prostaglandin A1: An effect associated with heat shock transcription factor activation. Proc Natl Acad Sci USA. 1997; 94: 746–50.PubMedCrossRefGoogle Scholar
  22. 22.
    Rossi A, Santoro MG. Induction by prostaglandin A1 of haem oxygenase in myoblastic cells: An effect independent of expression of the 70 kDa heat shock protein. Biochem J. 1995; 308: 455–63.PubMedGoogle Scholar
  23. 23.
    Rossi A, Elia G, Santoro MG. 2-Cyclopenten-l-one, a new inducer of heat shock protein 70 with antiviral activity. J Biol Chem. 1996; 271: 32192–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Amici C, Palamara AT, Santoro MG. Induction of thermotolerance by prostaglandin A in human cells. Exp Cell Res. 1993; 207: 230–4.PubMedCrossRefGoogle Scholar
  25. 25.
    Santoro MG. Antiviral activity of cyclopentenone prostanoids. Trends Microbiol. 1997; 5: 276–81.PubMedCrossRefGoogle Scholar
  26. 26.
    Santoro MG, Favalli C, Mastino A, Jaffe BM. Esteban M, Garaci E. Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus Arch Virol. 1988; 99: 89–100.CrossRefGoogle Scholar
  27. 27.
    Pica F, De Marco A, De Cesare F, Santoro MG. Inhibition of vesicular stomatitis virus replication by △12-prostaglandin J2 is regulated at two separate levels and is associated with induction of stress protein synthesis Antiviral Res. 1993; 20: 193–208.PubMedCrossRefGoogle Scholar
  28. 28.
    Rozera C, Carattoli A, De Marco A, Amici C, Giorgi C, Santoro MG. Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. J Clin Invest. 1996; 97: 1795–803.PubMedCrossRefGoogle Scholar
  29. 29.
    Baldwin AS. The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol. 1996; 14: 649–81.PubMedCrossRefGoogle Scholar
  30. 30.
    Bauerle PA, Baltimore D. NF-κB: Ten years after. Cell. 1996; 87: 13–20.CrossRefGoogle Scholar
  31. 31.
    Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells Nature. 1987; 326: 711–13.CrossRefGoogle Scholar
  32. 32.
    Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996; 97: 1715–22.PubMedCrossRefGoogle Scholar
  33. 33.
    Rupec RA, Baeuerle PA. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-I and NF-κB. Eur J Biochem. 1995; 234: 632–40.PubMedCrossRefGoogle Scholar
  34. 34.
    Stoltz RA, Abraham NG, Laniado-Schwartzman M. The role of NF-kappa B in the angiogenic response of coronary microvessel endothelial cells. Proc Natl Acad Sci USA. 1996; 93: 2832–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Lee S, Felts KA, Parry GC, Armacost LM, Cobb RR. Inhibition of 5-lipoxygenase blocks IL-1 beta-induced vascular adhesion molecule-I gene expression in human endothelial cells. J Immunol. 1997; 158: 3401–7.PubMedGoogle Scholar
  36. 36.
    Brach MA, de Vos S, Arnold C, Gruß HJ, Mertelsmann R, Herrmann F. Leukotriene B4 transcriptionally activates interleukin-6 expression involving NF-κB and NF-IL6. Eur J Immunol. 1992; 22.2705–11.PubMedCrossRefGoogle Scholar
  37. 37.
    Shield MJ. Novel applications of misoprostol. Pharmacol Ther. 1995; 65: 125–47.PubMedCrossRefGoogle Scholar
  38. 38.
    Sinclair SB, Greig PD, Blendis LM, et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. J Clin Invest 1989; 84: 1063–9.CrossRefGoogle Scholar
  39. 39.
    Lee J, Kannegiesser H, O’Toole J, Westura E. Hypertension and the renomedullary prostaglandins: A human study of the antihypertensive effects of PGA1. Ann NY Acad Sci. 1971; 180: 218–40.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • M. G. Santoro

There are no affiliations available

Personalised recommendations